TG THERAPEUTICS, INC. Gain (Loss) on Derivative Instruments, Net, Pretax
TG THERAPEUTICS, INC. (TGTX) reported Gain (Loss) on Derivative Instruments, Net, Pretax of -$2.10 million for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2011-11-14
- TG THERAPEUTICS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2011-09-30 was -$2.10M.
- TG THERAPEUTICS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2011-06-30 was -$2.23M, a 179.45% decline year-over-year.
- TG THERAPEUTICS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2010-09-30 was -$830.16K.
- TG THERAPEUTICS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2010-06-30 was $2.81M.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 119 month | Gain (Loss) on Derivative Instruments, Net, Pretax 122 month |
|---|---|---|---|---|---|
| 2011-09-30 | -$2.10M 10-Q · filed 2011-11-14 | -$4.33M derived: sum of 2 quarters · filed 2011-11-14 | $39.59K 10-Q · filed 2011-11-14 | -$2.46M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$2.23M 10-Q/A · filed 2011-09-14 | -$2.06M 10-Q/A · filed 2011-09-14 | $1.03M 10-Q/A · filed 2011-09-14 | ||
| 2010-09-30 | -$830.16K 10-Q · filed 2011-11-14 | $1.98M derived: sum of 2 quarters · filed 2011-11-14 | $2.70M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $2.81M 10-Q/A · filed 2011-09-14 | $1.87M 10-Q/A · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |